Assembly biosciences provides anticipated development milestones for 2024

South san francisco, calif., jan. 04, 2024 (globe newswire) -- assembly biosciences, inc. (nasdaq: asmb), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today provided an outline of the anticipated milestones and progress for its clinical pipeline during 2024.

ASMB Ratings Summary

ASMB Quant Ranking